CIK 0001728328
- Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 1 of 2 · 28 filings